Literature DB >> 8647641

Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position and differentiation.

J Bartkova1, M Zemanova, J Bartek.   

Abstract

The cyclin-dependent kinase 7 (CDK7) represents the 40-kDa catalytic subunit of the CDK-activating kinase, the enzyme responsible for activatory phosphorylation of multiple CDKs controlling G1, S and G2/M phases of the cell cycle. Here, we surveyed a wide range of normal and tumour cell types, in both cell culture and biopsy specimens, for abundance and subcellular localisation of the CDK7 protein. Immunoblotting and immunocytochemical analyses showed that CDK7 was (i) ubiquitously expressed in all cell types examined; (ii) exclusively nuclear; (iii) moderately elevated in tumour cells when compared with their normal cell counterparts; (iv) invariant throughout the cell cycle of normal lymphocytes, fibroblasts, breast epithelium and several cancer cell lines; and (v) clearly detectable even in quiescent cells, including highly differentiated cell types in situ. Our data are consistent with the emerging role for CDK7/CAK in multiple biological processes, possibly providing a link between cell-cycle control, transcriptional regulation and genomic integrity control.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647641     DOI: 10.1002/(SICI)1097-0215(19960611)66:6<732::AID-IJC4>3.0.CO;2-0

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Tumor extension and cell proliferation in adenocarcinomas of the lung.

Authors:  M Shoji; Y Dobashi; S Morinaga; S X Jiang; T Kameya
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.

Authors:  Jianguo Zhang; Junya Zhu; Lei Yang; Chengqi Guan; Runzhou Ni; Yuchan Wang; Lili Ji; Ye Tian
Journal:  Tumour Biol       Date:  2015-03-29

3.  Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.

Authors:  Jianguo Zhang; Xiaojing Yang; Yuchan Wang; Hui Shi; Chengqi Guan; Li Yao; Xianting Huang; Zongmei Ding; Yuejiao Huang; Huijie Wang; Chun Cheng
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

4.  Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer.

Authors:  Yan Zhou; Linlin Lu; Guanmin Jiang; Zhuojia Chen; Jiexin Li; Panpan An; Likun Chen; Jun Du; Hongsheng Wang
Journal:  Cell Death Differ       Date:  2018-11-19       Impact factor: 15.828

5.  Mat1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipocyte differentiation.

Authors:  Katja Helenius; Ying Yang; Jukka Alasaari; Tomi P Mäkelä
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

Review 6.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

7.  Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.

Authors:  Sharad S Singhal; David Horne; Jyotsana Singhal; Steven Vonderfecht; Ravi Salgia; Sanjay Awasthi
Journal:  Mol Carcinog       Date:  2019-04-21       Impact factor: 4.784

8.  Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer.

Authors:  Hetal Patel; Rezvan Abduljabbar; Chun-Fui Lai; Manikandan Periyasamy; Alison Harrod; Carolina Gemma; Jennifer H Steel; Naina Patel; Claudia Busonero; Dena Jerjees; Judit Remenyi; Sally Smith; Jennifer J Gomm; Luca Magnani; Balázs Győrffy; Louise J Jones; Frances Fuller-Pace; Sami Shousha; Laki Buluwela; Emad A Rakha; Ian O Ellis; R Charles Coombes; Simak Ali
Journal:  Clin Cancer Res       Date:  2016-06-14       Impact factor: 12.531

9.  Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.

Authors:  Jyotsana Singhal; Prakash Kulkarni; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Mol Carcinog       Date:  2021-02-05       Impact factor: 4.784

Review 10.  Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials.

Authors:  E Panagiotou; G Gomatou; I P Trontzas; N Syrigos; E Kotteas
Journal:  Clin Transl Oncol       Date:  2021-08-07       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.